Acute renal failure in patients with chronic kidney disease by Madala, ND
Acute renal failure (ARF) refers to sudden rapid decline (over 
hours to days) of glomerular filtration rate (GFR) that is usually 
reversible.1 The term ‘acute-on-chronic renal failure’ has been 
used when ARF occurs in the background of pre-existing chronic 
kidney disease. The term ‘acute-on-chronic kidney disease’ will 
be used in this review since chronic kidney disease (CKD) has 
largely replaced ‘chronic renal failure’ according to the National 
Kidney Foundation’s Kidney/Dialysis Outcomes Quality Initiative 
guidelines.2 
It is important to note that for assessment of renal function, 
measuring the urea and serum creatinine is inadequate since normal 
levels do not exclude renal disease. The GFR must be determined 
and the simplest method for estimating the GFR is through the use 
of GFR prediction equations that require the age, sex and ethnicity 
of the individual, as well as the serum creatinine. 
Epidemiology
Epidemiological data on acute-on-chronic kidney disease (acute-
on-chronic) are limited, as this entity has not been extensively 
investigated. However, there is clear evidence that pre-existing 
CKD is a strong risk factor for development of ARF, thus acute-
on-chronic forms a significant proportion of ARF. The risk of 
ARF increases with worsening baseline renal function, with a 
3-fold greater risk of ARF when creatinine clearance is < 60 ml/min 
compared with normal creatinine clearance, while the risk of about 
4.5 times has been reported in patients with creatinine clearance 
below 40 ml/min.3 The incidence of acute-on-chronic varies from 
10% to over 30%, depending on the study population. In one of 
the few community-based studies, acute-on-chronic was reported 
in almost 13% of patients presenting with ARF.4 In contrast, the 
incidence is higher in hospital-based studies, with acute-on-
chronic reported in 30% of ARF occurring in the USA, while the 
incidence was 33% in Australia and 35.5% in China.5-7 
Potentially reversible factors in CKD
Most of the recognised causes of ARF can cause acute-on-chronic 
and they are traditionally classified into prerenal, intrinsic renal 
and postrenal causes. This review focuses on the commonly 
encountered reversible causes that must be considered in patients 
with CKD who present with unexpectedly rapid deterioration of 
renal function. 
Prerenal causes 
In normal kidneys, renal blood flow and GFR remain remarkably 
constant despite wide variations in blood pressure. This is due 
to renal autoregulation, which determines the balance between 
vasodilatation of pre-glomerular or afferent arterioles, mediated by 
renal prostaglandins as well as nitric oxide and vasoconstriction 
of efferent or post-glomerular arterioles mediated by angiotensin 
II and endothelin, thus maintaining glomerular filtration pressure. 
Prerenal failure occurs when renal perfusion becomes diminished 
beyond the renal autoregulatory capacity. Pre-existing CKD is a 
major risk factor for prerenal failure and the mechanisms involved 
are briefly highlighted below.
Extracellular f luid volume depletion 
The ability of diseased kidneys to respond to extracellular 
fluid volume depletion is impaired because of their inability to 
concentrate the urine, which is lost early in the course of CKD. 
Extrarenal causes of volume depletion include haemorrhage, 
diarrhoea and vomiting, etc. Excessive diuresis resulting in 
volume depletion may occur in patients with CKD, especially with 
synergistic effects from concurrent use of different diuretic classes.8 
Osmotic diuresis from concurrent poorly controlled diabetes is 
another cause. Although fluid restriction is not a usual cause of 
ARF, CKD patients may develop severe dehydration in the pre-
operative period if fluids are restricted prior to surgery, resulting 
in acute-on-chronic. Therefore, fluid restriction must ensure that 
renal and extrarenal losses are replaced. 
Decreased effective circulating blood volume 
Co-morbid illnesses in CKD patients may include congestive 
cardiac failure, cardio-genic shock, nephrotic syndrome and 
hepatic cirrhosis. Renal haemodynamic changes resulting from 
these diseases are similar to those observed with volume depletion, 
and central venous pressure monitoring is necessary to guide fluid 
management in the presence of these concomitant disorders to 
prevent acute-on-chronic. Sepsis as well as septic shock presents 
another important and common cause of acute-on-chronic. 
Acute renal failure in patients with 
chronic kidney disease
Acute renal failure is a (usually) reversible decline in glomerular  
filtration rate over hours or days.
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Drug-induced haemodynamic renal 
failure
Altered renal haemodynamics resulting 
in prerenal failure is a common form of 
nephrotoxicity that CKD patients are at risk 
for.
•    Non-steroidal anti-inflammatory drugs. 
All non-steroidal anti-inflammatory 
drugs (NSAIDs) may induce ARF in 
patients with CKD since maintenance of 
renal perfusion is often prostaglandin-
dependent. A recent review of the 
literature on the renal effects of NSAIDs 
showed that selective COX-2 inhibitors, 
like the non-selective NSAIDs, cause ARF 
in patients with CKD and must be used 
cautiously or avoided in these patients.9 
Acute-on-chronic secondary to NSAID 
use may present with prerenal failure, 
acute tubular necrosis or acute interstitial 
nephritis.
•    Angiotensin-converting enzyme in-
hibitors and angiotensin II receptor 
blo ckers.  Angiotensin-conver t ing 
enzyme inhibitors (ACE-Is) and 
angiotensin II receptor blockers (ARBs) 
may precipitate acute-on-chronic in 
patients with bilateral renal artery stenosis 
since GFR in such patients is dependent 
on angiotensin II-mediated efferent 
arteriolar vasoconstriction. ACE-Is and 
ARBs reduce the synthesis as well as effect 
of angiotensin II, respectively, resulting in 
loss of the compensatory efferent arteriolar 
vasoconstriction; this precipitates a fall 
in GFR and worsening of renal function 
within 72 hours of starting treatment. 
However, renal function rapidly returns to 
baseline after drug withdrawal.10,11 Unlike 
NSAIDs, ACE-Is and ARBs do not usually 
cause acute tubular necrosis (ATN).
•    Radiocontrast agents. Iodinated contrast 
media have long been established as a 
cause of ARF and there is widespread 
evidence that the risk for contrast-induced 
nephrotoxicity is greatest in CKD patients 
with GFR below 60 ml/min.12 Gadolinium, 
used in magnetic resonance imaging, 
is also increasingly being recognised as 
nephrotoxic and a cause of acute-on-
chronic in patients with moderate as well 
as severe CKD.13 The incidence of acute-
on-chronic secondary to contrast-induced 
nephrotoxicity increases as the baseline 
serum creatinine increases, ranging 
from 2% if baseline serum creatinine 
is ≤ 105 µmol/l while increasing up to 
62% if baseline serum creatinine is ≥ 180 
µmol/l.14 The mechanism of contrast-
induced nephrotoxicity is complex and 
poorly understood but it appears to 
be mediated through hypoxic tubular 
damage in the renal medulla due to 
alterations in the renal microcirculation 
as well as through increased oxygen 
consumption for solute reabsorption. 
Structural as well as functional ab-
normalities of CKD such as defective 
nitric-oxide-dependent vasodilatation, 
impaired renal prostaglandins synthesis 
and increased reabsorptive workload 
by surviving nephrons thus render the 




Patients with CKD are at risk for ATN, which 
occurs as a result of ischaemia or exposure to 
nephrotoxins. Ischaemic ATN is the result of 
uncorrected prolonged renal hypoperfusion 
and most of the causes of prerenal failure 
have the potential to cause ATN. Toxic ATN 
is due to direct tubular epithelial injury 
by both endogenous toxins, as is the case 
with myoglobinuric ARF, myeloma kidney, 
hypercalcaemia, etc., as well as exogenous 
nephrotoxins such as aminoglycosides, 
radiocontrast agents, etc.8,15 Acute-on-
chronic may also complicate treatment 
with amphotericin B, which causes both 
ischaemic and toxic tubular injury.15,16 
Acute interstitial nephritis 
Acute drug-induced interstitial nephritis is 
a common cause of intrinsic ARF that can 
lead to acute-on-chronic in CKD patients. 
Common precipitants are NSAIDs and 
penicillins. Infections cause direct dam-
age to the tubulointerstitium resulting in 
acute pyelonephritis. However, infection-
associated acute interstitial nephritis is 
immunologically mediated.17  
Crystal-induced ARF
Pre-existing CKD is also an important risk 
factor for the development of crystal-induced 
ARF. Some of the commonly used drugs 
associated with crystal-induced ARF include 
acyclovir, sulphonamides and indinavir.8,18 
Recognition of these drugs, commonly 
indicated in immunocompromised patients, 
as a cause of acute-on-chronic is important 
as the burden of CKD among patients with 
human immunodeficiency virus (HIV) 
infection is likely to grow because of the 
expected improved survival of HIV-infected 
patients following the recent country-wide 
introduction of highly active antiretroviral 
treatment. 
Severe hypertension
Accelerated phase or malignant hyper-
tension may present with oliguric ARF 
with recovery of renal function if adequate 
blood pressure control is achieved.19 The 
time period to renal function recovery is 
variable and has been observed within 10 
days, ranging up to 9 months with optimal 
blood pressure control, as well as dialysis 
support where indicated. Prognosis for 
renal recovery is better in patients who 
have normal kidney size and those with 
concurrent ATN on renal histology.19 Acute-
on-chronic developing after commencing 
ACE-I in a hypertensive patient is an in-
dication to search for renal artery stenosis. 
Relapse or progression of underlying 
disease
Rapidly progressive glomerulonephritis 
must be considered in someone presenting 
with ARF as well as in previously stable 
patients known to have glomerulonephritis 
who develop sudden, rapid unexpected 
decline in GFR or rising serum creatinine, 
since early treatment may lead to sufficient 
renal recovery and may obviate the need 
for chronic dialysis and transplantation. 
Acute-on-chronic may be a manifestation 
of relapse of disease activity in patients with 
CKD due to lupus nephritis. Flare-up of 
lupus nephritis accounted for 20% of acute-
on-chronic in the previously cited Chinese 
study.4 
Postrenal causes
Obstruction of the upper and lower urinary 
tracts may occur in the setting of pre-
existing CKD whether CKD is due to an 
obstructive or another cause, and should be 
considered in all patients presenting with 
acute-on-chronic. Urgent intervention is 
critical to limit renal damage and preserve 
residual renal function in these patients. 
Obstruction can be immediately excluded 
by non-invasive imaging, i.e. ultrasono-
graphy, computed tomography and magnetic 
resonance imaging. Relief of obstruction 
often requires early urology referral.
Diagnostic approach and 
management of acute-on-
chronic kidney disease
The approach to diagnosis of any patient 
presenting acutely with renal failure should 
mainly address the following two issues:
Co-morbid illnesses in CKD patients 
may include congestive cardiac failure, 
cardiogenic shock, nephrotic syndrome 
and hepatic cirrhosis.
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•    Is the renal failure acute or is it acute-on-
chronic?
•    Identifying and managing potentially 
reversible causes.
Establishing whether renal failure is 
acute or acute-on-chronic
•    History may indicate the presence of pre-
existing renal disease or predisposing 
factors for CKD, the common risk factors 
being hypertension, diabetes mellitus, 
autoimmune disease, chronic analgesic 
use, etc.
•   Clues on clinical examination include 
proteinuria and/or haematuria on 
dipstix examination, which may suggest 
glomerular disease. Other clues are the 
presence of extrarenal organ involvement 
like hypertensive heart disease and/
or retinopathy; diabetic micro- and 
macrosvascular complications and extra-
renal manifestations of systemic lupus 
erythematosus.
•    Useful investigations include previous 
results of serum creatinine and, where 
available, a sudden increase of more 
than 25 - 50% from baseline serum 
creatinine usually indicates acute-on-
chronic. Ultrasound usually shows 
shrunken kidneys with the exception of 
diabetic nephropathy, amyloidosis, HIV-
associated nephropathy and autosomal 
dominant polycystic kidney disease, 
in which kidney size usually remains 
preserved.
Identification and management of 
acute-on-chronic kidney disease 
Table I summarises the clinical approach 
to the diagnosis as well as the appropriate 
management of the reversible causes of 
deteriorating renal function in CKD patients 
commonly encountered in clinical practice. 
History and physical examination will often 
give clues to the likely cause of the acute 
deterioration.  In prerenal causes of acute-
on-chronic, evidence of hypovolaemia is 
easily established through insertion of a 
central venous catheter and confirmation 
Table I. Diagnosis and management of common reversible causes of acute renal failure in patients with CKD
History               Clinical features      Specific investigations                 Management
Prerenal causes
•    Gastrointestinal loss: 
diarrhoea, vomiting, etc.
•    Skin loss: excess sweating, 
burns
•    Renal loss: diuretics, osmotic 
diuresis, etc.
•   Haemorrhage
•   Symptoms of cardiac failure
•    History may suggest other 
oedema states
•   Signs of dehydration: dry oral 
mucosa, reduced skin turgor, 
etc. and hypotension
•   Skin and renal losses may 
have same features as above
•   Above and clues to the source 
of bleeding
•   Signs of congestive cardiac 
failure/ cardiogenic shock
•   Signs suggestive of cirrhosis 
or nephrotic syndrome
•   Central venous catheter 
insertion and monitoring 
usually show low central 
venous pressure (CVP) 
except in congestive cardiac 
failure/ cardiogenic shock
•   Fluid resuscritation and 
restoration of hypovolaemia
•   Inotropic drugs may be 
indicated in congestive 




•    History of above prerenal 
causes
•    History of nephrotoxic or 
crytal-inducing drug
•    Pyelonephritis and systemic 
infection
•   Autoimmune flares may 
be suspected from history 
or from routine serological 
surveillance tests
•  Accelerated hypertension
•   Signs of dehydration, low 
BP, etc.
•  Nonspecitic signs
•  Clinical signs of infection
•   Recurrence or worsening 
of proteinuria and/or 
haematuria on urine dipstick 
testing
•   Extrarenal features may be 
present 
•   Severe hypertension, grade 
III/ IV retinopathy and 
worsening renal function
•   Low CVP as above
•   No specitic tests needed
•    Microscopy and culture of 
urine/ blood/ sputum
•    Specific serological tests, 




•   Renal biopsy
•   Clinical diagnosis
•   Fluid replacement
•   Withdraw offending drug
•    Appropriate antibiotic 
therapy
•    Nephrology referral 
for renal biopsy and 
immunosuppressive therapy 
is required to reverse 
acute-on-chronic or prevent 
further loss
•   Blood pressure control
Postrenal causes
•   Symptoms of urinary            •  Distended, palpable bladder    • Ultrasound shows   •   Urology referral and relief 
     retention and/ or            hydronephrosis       of obstruction is required 
     prostatism
•   Symptoms of cystitis            •  Prostate enlargement    •   Urine microscopy and culture     
     (dysuria suprapubic             showing infection      
     pain, etc.)
•   Ureteric colic            •  Variable abdominal     •   Renal calculi on X-ray or      
                 tenderness  suprapubic, flank         ultrasound
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of a low central venous pressure. Fluid 
resuscitation and volume replacement will 
usually be adequate to restore renal function 
back to its baseline level. However, once 
ischaemic ATN is established, temporary 
dialysis may be indicated until renal recovery 
back to baseline occurs. Inotropic drugs are 
required to restore renal perfusion and renal 
function in patients who develop acute-on-
chronic as a result of cardiogenic shock.
Similarly, postrenal causes are often evident 
on history as well as physical examination, 
and obstruction can be confirmed with 
non-invasive imaging like ultrasonography, 
which must be done urgently to facilitate 
timeous relief of obstruction before 
permanent renal damage has ensued. Relief 
of obstruction leads to reversal of renal 
function deterioration and recovery back to 
baseline or renal function stabilisation. 
Once prerenal and postrenal causes of 
acute-on-chronic have been excluded 
clinically and on the simple investigations 
discussed, an intrinsic renal cause must 
be sought, which might require special 
investigations. In drug-induced acute-
on-chronic, withdrawal of the offending 
drug may be all that is required. Systemic 
infections and pyelonephritis must be treated 
according to results of microscopy, culture 
and antimicrobial sensitivity. Accelerated 
hypertension requires modification of the 
antihypertensive treatment regimen. It is 
important to ensure compliance with salt 
restriction, so a dietician must be consulted 
to optimise adherence to diet therapy and 
limit the potential for dietary salt indiscretion 
as a cause for poor blood pressure control. 
If there are indications, dialysis may be 
required for a variable period until baseline 
renal function is achieved.  
Suspected relapse of lupus nephritis as 
well as rapidly progressive renal disease 
due to other glomerulonephritides like 
the vasculitides must be confirmed with 
appropriate specific serological tests, i.e. 
antinuclear antibodies, serum complement, 
antineutrophil cytoplasmic antibodies, 
etc. A renal biopsy is required to confirm 
the diagnosis as well as assess histological 
activity and disease stage in order to 
guide further decisions regarding the 
immunosuppressive therapeutic regimen. 
Temporary dialysis may be required, where 
indicated, as discussed with all other causes 
of acute-on-chronic.
Conclusion
Prevention of ARF is crucial in CKD patients 
in whom the ultimate goal is preserving renal 
function and delaying the onset of end-stage 
renal disease. Once acute-on-chronic has 
developed it is mandatory to look for the 
cause and removal of the precipitating factor 
and/or appropriate treatment will often 
result in recovery or stabilisation of renal 
function.
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In a nutshell 
∙    Chronic kidney disease (CKD) patients are at a high risk for acute renal failure.
∙    Glomerular filtration rate must be estimated in all patients with hypertension, diabetes and other CKD risk factors for diagnosis and 
staging of CKD.
∙    Always look for reversible causes in patients presenting with renal failure.
∙    Correction of hypovolaemia and hypotension restores baseline renal function in prerenal causes.
∙    Immediate relief of obstruction is critical to prevent further kidney damage in postrenal acute-on-chronic.
∙    Avoid NSAIDs, nephrotoxic antimicrobials and radiocontrast agents in CKD patients.
∙    ACE-Is and ARBs must be stopped if serum creatinine increases more than 15% from baseline value within a week of starting treat-
ment.
∙    Optimal BP control may result in renal recovery in accelerated phase hypertension.
∙    Urgent referral for renal biopsy is mandatory where recurrence of active lupus nephritis or rapidly progressive glomerulonephritis are 
suspected.
∙    Preserving renal function and delaying onset of chronic dialysis is the ultimate goal in the care of CKD patients.
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